Infectious Diseases News and Research

RSS

Newly designed drugs could help combat any potential flu pandemic

Researchers at LSTM and Imperial College London have designed drugs which could help combat any potential new flu pandemic, by targeting the receptors of the cells by which the virus gains entry to the human body.

28 Jan 2019

NIH researchers discover that anti-flu antibodies can inhibit two different viral proteins

Researchers from the National Institutes of Health have discovered that antibodies that may form the basis of a universal flu vaccine inhibit a second viral protein in addition to the one that they bind.

25 Jan 2019

Investigational Ebola treatment found to be safe in adults

The investigational Ebola treatment mAb114 is safe, well-tolerated, and easy to administer, according to findings from an early-stage clinical trial published in The Lancet.

25 Jan 2019

Ebola virus identified in a West African bat

The government of Liberia, in partnership with the Center for Infection and Immunity (CII) at the Columbia University Mailman School of Public Health and EcoHealth Alliance, announced the discovery of Ebola virus in a bat in Liberia.

24 Jan 2019

Researchers demonstrate strong evidence connecting bacterial pathogen and Alzheimer's pathogenesisis

New science uncovers how an unlikely culprit, Porphyromonas gingivalis (Pg) - the bacterium commonly associated with chronic gum disease - appears to drive Alzheimer's disease (AD) pathology.

24 Jan 2019

African scientists to build research capacity in African countries, develop ongoing scientific partnerships

Ten African scientists have been selected for training at the National Institutes of Health as part of a new fellowship program to build research capacity in African countries and develop ongoing scientific partnerships.

24 Jan 2019

CMV vaccine provides a new way to fight malaria

Early research on a new approach to protecting against malaria is offering promising, potentially long-lasting results against the persistent parasite that sickens hundreds of millions people each year.

24 Jan 2019

LJI awarded $22 million contract renewal to host and expand Immune Epitope Database

La Jolla Institute for Immunology has been awarded a $22 million contract renewal over seven years from the National Institutes of Health to host and expand the Immune Epitope Database.

24 Jan 2019

Transmissible cancer in Tasmanian devils unlikely to cause extinction, study reveals

A new study of Tasmanian devils has revealed that a transmissible cancer which has devastated devil populations in recent years in unlikely to cause extinction of the iconic species.

24 Jan 2019

FDA grants clearance to Hologic’s assay for detection of common sexually transmitted infections

Hologic, Inc. announced today that the U.S. Food and Drug Administration (FDA) has granted clearance for its Aptima Mycoplasma genitalium assay, the first and only FDA-cleared test to detect this under-recognized but increasingly common sexually transmitted infection (STI).

23 Jan 2019

£20 million research hub could improve health, life prospects of African youth

A long-term initiative championed by the UK Research and Innovation Council could significantly improve the health and life prospects of a generation of Africa's youth.

23 Jan 2019

Clinical testing begins for temperature-stable experimental tuberculosis vaccine

Vaccinations have begun in a Phase 1 human clinical trial testing a freeze-dried, temperature-stable formulation of an experimental tuberculosis vaccine candidate.

23 Jan 2019

Unique form of chronic sinusitis found in older patients

Older patients with a diagnosis of chronic sinusitis -- a disease of the nasal cavity and paranasal sinuses that often persists over many years -- have a unique inflammatory signature that may render them less responsive to steroid treatment, according to a new study published by Vanderbilt researchers.

23 Jan 2019

Study: Prior dengue immunity in children may be protective against symptomatic Zika

Children with a history of prior dengue virus infection had a significantly lower risk of being symptomatic when infected by Zika virus, according to a study in Nicaragua of more than 3,000 children aged 2 to 14 years.

23 Jan 2019

Researchers create new micro-dispenser for storage and controlled release of liquids

Lab-on-a-chip technology could transform medicine in ways comparable with how microprocessors have changed our everyday lives - that is once it can be manufactured in a scalable cost-effective way. Researchers in Sweden now report a development that could speed this revolution up.

23 Jan 2019

TGen identifies polio-like virus as potential cause of Acute Flaccid Myelitis outbreak

The Translational Genomics Research Institute, an affiliate of City of Hope, has identified a polio-like virus as a potential cause of an outbreak of a disease known as Acute Flaccid Myelitis (AFM), a crippling condition that causes muscle weakness and paralysis usually among children.

23 Jan 2019

Study: Prior dengue infection could protect children from symptomatic Zika

A prior dengue virus infection could protect children from symptomatic Zika virus infection, according to a study by an international group of researchers including those from the University of Michigan and the University of California, Berkeley.

23 Jan 2019

New findings challenge existing strategies for fighting infectious diseases and germs

Do the same laws of biodiversity which apply in nature also apply to our own bodies and homes? If so, current hygiene measures to combat aggressive germs could be, to some extent, counterproductive.

22 Jan 2019

Migrants and refugees do not bring disease and are at greater health risk themselves says WHO

The irregular migrant refugees coming to European nations are often accused on bringing with them host of exotic communicable diseases that tend to spread among the host communities. The World Health Organization (WHO) this week has absolved the migrants of spreading disease in its first report that deals with this issue.

22 Jan 2019

WHO identifies non-communicable diseases as major threat to human health

Second on the list are non-communicable diseases including cancer, heart disease, stroke, diabetes etc. The WHO report states that around 70 percent of the deaths are caused by these non-communicable diseases.

21 Jan 2019

Infectious Diseases News and Research

Newly designed drugs could help combat any potential flu pandemic

NIH researchers discover that anti-flu antibodies can inhibit two different viral proteins

Investigational Ebola treatment found to be safe in adults

Ebola virus identified in a West African bat

Researchers demonstrate strong evidence connecting bacterial pathogen and Alzheimer's pathogenesisis

African scientists to build research capacity in African countries, develop ongoing scientific partnerships

CMV vaccine provides a new way to fight malaria

LJI awarded $22 million contract renewal to host and expand Immune Epitope Database

Transmissible cancer in Tasmanian devils unlikely to cause extinction, study reveals

FDA grants clearance to Hologic’s assay for detection of common sexually transmitted infections

£20 million research hub could improve health, life prospects of African youth

Clinical testing begins for temperature-stable experimental tuberculosis vaccine

Unique form of chronic sinusitis found in older patients

Study: Prior dengue immunity in children may be protective against symptomatic Zika

Researchers create new micro-dispenser for storage and controlled release of liquids

TGen identifies polio-like virus as potential cause of Acute Flaccid Myelitis outbreak

Study: Prior dengue infection could protect children from symptomatic Zika

New findings challenge existing strategies for fighting infectious diseases and germs

Migrants and refugees do not bring disease and are at greater health risk themselves says WHO

WHO identifies non-communicable diseases as major threat to human health

eBook: Advancing infectious disease vaccine development eBook

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Advancing Intracellular Delivery with LumiPore®

Latest News